Dr. Girotra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Summary
- Dr. Monica Girotra is an endocrinologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Weill Cornell Medicine and has been in practice 17 years. She specializes in pituitary disorders & neuroendocrinology. She has more than 20 publications and over 500 citings.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2006
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2000 - 2003
- Weill Cornell MedicineClass of 2000
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2006 - 2025
- NY State Medical License 2002 - 2025
Publications & Presentations
PubMed
- 27 citationsImmune Checkpoint Inhibitor-Associated Diabetes: A Single-Institution Experience.David J. Byun, Rebecca Braunstein, Jessica Flynn, Junting Zheng, Robert A. Lefkowitz
Diabetes Care. 2020-10-13 - 19 citationsMultinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary to...Vickie R. Shannon, Ronald Anderson, Ada G. Blidner, Jennifer N. Choi, Tim Cooksley
Supportive Care in Cancer. 2020-09-03 - 22 citationsCancer immunotherapy-related adverse events: causes and challenges.Ada G. Blidner, Jennifer N. Choi, Tim Cooksley, Michael Dougan, Ilya G. Glezerman
Supportive Care in Cancer. 2020-08-28
Press Mentions
- Clinical Challenge: Immunotherapy-Related Diabetes in Cancer PatientsJune 25th, 2021
- A Lifesaver with a Catch: Powerful New Cancer Drugs Can Trigger Diabetes — and No One Is Certain WhyMay 29th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: